The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine, claiming the company had not used an appropriate control group in its pivotal ...
We know you’re busy, so we’ve got your back. Our curators conduct research to create guides and recommend local businesses, independently of the newsroom. All advertising is disclosed. AI tools helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results